Product Categories
| Country: | United States |
|---|---|
| Tel: | +1-781-999-5354 |
| Mobile: | +1-00000000000 |
| E-mail: | info@targetmol.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 36 Washington Street, Wellesley Hills |
|
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
|
| Product Name | MF | CAS | Details |
|---|
| (S,R,S)-AHPC-PEG4-NH2；VH032-PEG4-NH2;E3 ligase Ligand-Linker Conjugates 7 Free Base;VHL Ligand-Linker Conjugates 4 | C32H49N5O8S | 2010159-57-4 | Details |
| PROTAC ERRα ligand 1 | C19H11F3N2O4S | 1264754-13-3 | Details |
| Eact | C22H24N2O5S | 461000-66-8 | Details |
| EBI-2511 | C34H48N4O4 | 2098546-05-3 | Details |
| EBI-1051 | C18H15F2IN2O5 | 1801896-05-8 | Details |
| Ebrotidine；FI3542 | C14H17BrN6O2S3 | 100981-43-9 | Details |
| Aliskiren hemifumarate；CGP 60536;CGP60536B;SPP 100 | C30H53N3O6 | 173334-58-2 | Details |
| Edicotinib；JNJ-40346527;JNJ-527 | C27H35N5O2 | 1142363-52-7 | Details |
| Rimonabant；SR141716 | C22H21Cl3N4O | 168273-06-1 | Details |
| Edotecarin；PF 804950;J 107088 | C29H28N4O11 | 174402-32-5 | Details |
| Echinomycin；NSC-13502;Quinomycin A | C51H64N12O12S2 | 512-64-1 | Details |
| EC23；BASF-46928;AGN 190205 | C23H24O2 | 104561-41-3 | Details |
| Edasalonexent；CAT-1004 | C31H42N2O3 | 1204317-86-1 | Details |
| MAK683 | C20H17FN6O | 1951408-58-4 | Details |
| Elucaine | C19H23NO2 | 25314-87-8 | Details |
| (±)-10-Hydroxycamptothecin；Hydroxy Camptothecine;10-Hydroxycamptothecin | C20H16N2O5 | 64439-81-2 | Details |
| Emicerfont；GW876008 | C22H24N6O2 | 786701-13-1 | Details |
| EL-102 | C19H16N2O3S2 | 1233948-61-2 | Details |
| EHT 1610；EHT 5372 | C18H14FN5O2S | 1425945-60-3 | Details |
| Elobixibat；A 3309;AZD 7806 | C36H45N3O7S2 | 439087-18-0 | Details |
| Eleclazine hydrochloride；GS 6615 hydrochloride | C21H17ClF3N3O3 | 1448754-43-5 | Details |
| EF-5；EF5;2-Nitroimidazole | C8H7F5N4O3 | 152721-37-4 | Details |
| EGNHS；EGS crosslinker | C18H20N2O12 | 70539-42-3 | Details |
| Elsulfavirine；Elpida;VM-1500 | C24H17BrCl2FN3O5S | 868046-19-9 | Details |
| Eldecalcitol；ED-71;2-(3-hydroxypropoxy)-1,25-dihydroxyvitamin D3 | C30H50O5 | 104121-92-8 | Details |
| Emamectin Benzoate；MK-244 | C49H77NO13 | 155569-91-8 | Details |
| Emiglitate；BAY o 1248 | C17H25NO7 | 80879-63-6 | Details |
| Elisartan；HN 65021 | C27H29ClN6O5 | 149968-26-3 | Details |
| EML 425 | C27H24N2O4 | 1675821-32-5 | Details |
| Emeramide；BDTH2 | C12H16N2O2S2 | 351994-94-0 | Details |
| TBC3711；Endothelin Mordulator 1 | C20H21N3O5S2 | 349453-49-2 | Details |
| Entasobulin | C26H18ClN3O2 | 501921-61-5 | Details |
| Teniposide；NSC 122819;VM26 | C32H32O13S | 29767-20-2 | Details |
| EN460 | C22H12ClF3N2O4 | 496807-64-8 | Details |
| endo-BCN-PEG4-NHS ester | 1807501-86-5 | Details |
| endo-BCN-PEG2-PFP ester | C24H26F5NO6 | 1421932-53-7 | Details |
| endo-BCN-PEG4-Boc | C26H43NO8 | 1807501-83-2 | Details |
| Enbucrilate；Butyl cyanoacrylate | C8H11NO2 | 6606-65-1 | Details |
| FAAH-IN-2；O-Desmorpholinopropyl Gefitinib | C15H11ClFN3O2 | 184475-71-6 | Details |
| Enocitabine | C31H55N3O6 | 55726-47-1 | Details |
| Tazemetostat trihydrochloride；EPZ-6438 trihydrochloride;E-7438 trihydrochloride | C34H45ClN4O4 | 1403255-00-4 | Details |
| Evenamide；NW-3509 | C16H26N2O2 | 1092977-61-1 | Details |
| endo-BCN-PEG4-PFP ester | C28H34F5NO8 | 1421932-52-6 | Details |
| endo-BCN-PEG3-acid | C20H31NO7 | 1807501-82-1 | Details |
| endo-BCN-PEG3-NH-Boc | C24H40N2O7 | 1807501-84-3 | Details |
| Endovion；NS3728 | C16H9BrF6N6O | 265646-85-3 | Details |
| F16 | C16H15IN2 | 36098-33-6 | Details |
| Nilotinib；AMN107;Tasigna | C28H22F3N7O | 641571-10-0 | Details |
| endo-BCN-PEG8-NHS ester | C34H54N2O14 | 1608140-48-2 | Details |
| Enarodustat；JTZ-951 | C17H16N4O4 | 1262132-81-9 | Details |
| Eperezolid；PNU-100592 | C18H23FN4O5 | 165800-04-4 | Details |
| EZ-482 | C23H19ClN4O5S | 1016456-76-0 | Details |
| EN40 | C13H15NO2 | 2094547-67-6 | Details |
| Epoprostenol sodium；Prostaglandin I2 sodium salt;Prostacyclin sodium salt;Flolan | C20H33NaO5 | 61849-14-7 | Details |
| Epristeride；ONO-9302;SKF105657 | C25H37NO3 | 119169-78-7 | Details |
| ENMD-1198；ENMD-119;ENMD 1198;IRC 110160 | C20H25NO2 | 864668-87-1 | Details |
| endo-BCN-PEG4-acid | 1421932-54-8 | Details |
| endo-BCN-PEG2-acid | C18H27NO6 | 1993134-72-7 | Details |
| GPR40 agonist 4 | C21H17ClO5S | 2102196-57-4 | Details |
| Iopromide；Ultravist;Iopromidum | C18H24I3N3O8 | 73334-07-3 | Details |
| endo-BCN-PEG2-alcohol | C17H27NO5 | 1807501-85-4 | Details |
| endo-BCN-PEG8-acid | C30H51NO12 | 2126805-02-3 | Details |
| Ritonavir；ABT 538;RTV;Abbott 84538;A 84538 | C37H48N6O5S2 | 155213-67-5 | Details |
| Fenobam | C11H11ClN4O2 | 57653-26-6 | Details |
| Ethyl acetoacetate；Ethyl acetylacetate | C6H10O3 | 141-97-9 | Details |
| Denifanstat；TVB-2640;TVB2640;FASN-IN-2 | C27H29N5O | 1399177-37-7 | Details |
| Nifuratel；SAP 113;NF 113;Methylmercadone | C10H11N3O5S | 4936-47-4 | Details |
| Estetrol | C18H24O4 | 15183-37-6 | Details |
| Erythromycin estolate | C52H97NO18S | 3521-62-8 | Details |
| Etofylline clofibrate | C19H21ClN4O5 | 54504-70-0 | Details |
| CCX354 | C22H22ClN7O2 | 1010073-75-2 | Details |
| Vactosertib Hydrochloride；EW-7197 Hydrochloride;TEW-7197 Hydrochloride | C22H19ClFN7 | 1352610-25-3 | Details |
| Ferroquine；SSR97193;Ferrochloroquine | C18H19ClN3.C5H5.Fe | 185055-67-8 | Details |
| ER-000444793 | C23H18N2O2 | 792957-74-5 | Details |
| Febantel | C20H22N4O6S | 58306-30-2 | Details |
| Fiacitabine；FIAC;FOAC;NSC 382097 | C9H11FIN3O4 | 69123-90-6 | Details |
| Esaxerenone；CS-3150;XL-550 | C22H21F3N2O4S | 1632006-28-0 | Details |
| ETC-206 | C25H20N4O2 | 1464151-33-4 | Details |
| Fezolinetant；ESN-364 | C16H15FN6OS | 1629229-37-3 | Details |
| Etripamil；(-)-MSP-2017;MSP-2017 | C27H36N2O4 | 1593673-23-4 | Details |
| FEN1-IN-1；LNT-1 | C15H12N2O5S | 824983-91-7 | Details |
| Etersalate；Etherylate;Eterylate | C19H19NO6 | 62992-61-4 | Details |
| Gliclazide；SE1702;S1702 | C15H21N3O3S | 21187-98-4 | Details |
| Fedovapagon | C27H34N4O3 | 347887-36-9 | Details |
| Etilevodopa；L-DOPA ethyl ester;Levodopa ethyl ester | C11H15NO4 | 37178-37-3 | Details |
| Evatanepag；CP-533536 free acid | C25H28N2O5S | 223488-57-1 | Details |
| Selisistat R-enantiomer；EX-527 (R-enantiomer) | C13H13ClN2O | 848193-69-1 | Details |
| Ertiprotafib；PTP 112 | C31H27BrO3S | 251303-04-5 | Details |
| FHZ | C26H26N2O7 | 1883737-63-0 | Details |
| Etebenecid；Urelim | C11H15NO4S | 1213-06-5 | Details |
| Fananserin；RP 62203 | C23H24FN3O2S | 127625-29-0 | Details |
| Estrogen receptor modulator 1 | C14H10O2S | 63676-22-2 | Details |
| Ertugliflozin L-pyroglutamic acid；PF-04971729 L-pyroglutamic acid | C27H32ClNO10 | 1210344-83-4 | Details |
| Euphorbadienol；alpha-Euphorbol | C31H52O | 566-14-3 | Details |
| Fervenulin | C7H7N5O2 | 483-57-8 | Details |
| ESI-05；NSC 116966 | C16H18O2S | 5184-64-5 | Details |
| Evocalcet；KHK7580 | C24H26N2O2 | 870964-67-3 | Details |
| Azasetron hydrochloride；Y-25130 hydrochloride;Azasetron HCl;Y-25130 HCl | C17H21Cl2N3O3 | 123040-16-4 | Details |
| Falecalcitriol | C27H38F6O3 | 83805-11-2 | Details |
| Ercalcidiol；25-hydroxy Vitamin D2 | C28H44O2 | 21343-40-8 | Details |
| Product Total： Product Page： | ||||
| 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 | ||||